# The Vascutek Rapidax™ II Post Market Surveillance Registry

> **NCT01977508** · — · TERMINATED · sponsor: **Vascutek Ltd.** · enrollment: 24 (actual)

## Conditions studied

- End Stage Kidney Disease

## Interventions

- **DEVICE:** ePTFE vascular access grafts

## Key facts

- **NCT ID:** NCT01977508
- **Lead sponsor:** Vascutek Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977508, "The Vascutek Rapidax™ II Post Market Surveillance Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01977508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*